Ninety percent of diagnostic technologies that clear validation never achieve sustainable adoption. The science works. The clinical data exists. Yet these innovations stall in the gap between the laboratory and the clinic.
Diagnostics Does Not Have a Science Problem. It Has a Commercialization Problem. The cause is structural, not scientific. Evidence generation, regulatory strategy, reimbursement pathways, and market placement are treated as isolated silos.
Architect diagnostic innovation toward adoption through commercial infrastructure designed for sustainable revenue.
Scott Robitaille, Founder and Chief Commercial Strategist. Experience across the full diagnostic commercialization stack. Acute care laboratories, decentralized care, health system platforms, molecular platforms, and benchmark measurable business models.
AdvisoryDx exists because the diagnostic industry consistently misdiagnoses commercial risk.
Traditional consulting delivers recommendations. Architecture delivers infrastructure. Our methodology sequences six decision layers: Market and Category Strategy, Evidence and Adoption Strategy, Channel and Distribution Architecture, Reimbursement and Access Strategy, Launch Sequencing and Field Strategy, and Stakeholder and Investor Alignment.
Institutional Access, Channel Authority, and Field Credibility — built over 25+ years inside the diagnostic ecosystem.